Nippon India Taiwan Equity Fund vs UTI - Healthcare Fund
Direct Plan, Growth option · Data as on 30-10-2026
Nippon India Taiwan Equity Fund is a Thematic fund and UTI - Healthcare Fund is a Thematic fund. In the 3 years to 30-10-2026, Nippon India Taiwan Equity Fund (Direct) returned 54.8% a year and UTI - Healthcare Fund (Direct) returned 23.5% a year. Nippon India Taiwan Equity Fund charges 1.08% a year and UTI - Healthcare Fund 1.35% (Direct plans). Their portfolios overlap 0.0%: they hold 0 of the same securities.
Nippon India Taiwan Equity Fund
Thematic
- 3 year return
- 54.8%
- Expense ratio
- 1.08%
- NAV
- ₹31.86
UTI - Healthcare Fund
Thematic
- 3 year return
- 23.5%
- Expense ratio
- 1.35%
- NAV
- ₹375.09
Which is better, Nippon India Taiwan Equity or UTI - Healthcare? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Nippon India Taiwan Equity returned more over 3 years: 54.8% a year against 23.5%.
- Nippon India Taiwan Equity returned more over 1 year: 75.7% against 13.5%.
- Nippon India Taiwan Equity costs less: 1.08% a year against 1.35% (Direct plans).
- UTI - Healthcare swung less over 3 years: a standard deviation of 13.5% a year against 35.3%.
- UTI - Healthcare fell less in its worst fall since 14-12-2021: −19.4% against −44.8%.
- Nippon India Taiwan Equity holds 90.8% of the fund in foreign stocks; UTI - Healthcare 0.0%.
- UTI - Healthcare holds more in large companies: 18.2% of the fund in large caps against 0.0%.
- UTI - Healthcare is the larger fund: ₹1,430 Cr against ₹1,147 Cr.
- Their portfolios overlap 0.0%: 0 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Nippon India Taiwan Equity Fund | UTI - Healthcare Fund |
|---|---|---|
| Fund house | Nippon India Mutual Fund | UTI Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹1,147 Cr (30-09-2026) | ₹1,430 Cr (30-09-2026) |
| NAV | ₹31.86 (Direct) | ₹375.09 (Direct) |
| Expense ratio (Direct) | 1.08% | 1.35% |
| Expense ratio (Regular) | 2.36% | 2.23% |
| Riskometer | Very High | Very High |
| Benchmark | Taiwan Capitalization Weighted Stock Index (TAIEX) | BSE Healthcare TRI |
| Launch date | 11-12-2021 | 28-06-1999 |
| Minimum investment | 500; Note - Lumpsum subscription under the Scheme is suspended temporarily with effect from February 26, 2024 | Regular Plan-Growth- Rs.5000, Regular Plan-Reinvestment of IDCW- Rs.5000, Regular Plan-Payout of IDCW- Rs.5000, Direct Plan-Growth- Rs.5000, Direct Plan-Reinvestment of IDCW- Rs.5000, Direct Plan-Payout of IDCW- Rs.5000, |
| Lock in | None | None |
| Fund managers | Kinjal Desai | Kamal Gada FM 1, Not Applicable FM 2, Not Applicable FM 3 |
| Exit load | 1% if redeemed or switched out on or before completion of 3 months from the date of allotment of units. Nil, thereafter | 1.00% if redeemed before 30 days from the date of allotment. Nil if redeemed on or after 30 days from the date of allotment |
Nippon India Taiwan Equity vs UTI - Healthcare: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund (Direct) | −16.05% | +11.27% | −9.87% | +75.71% | +54.78% | -- | -- |
| UTI - Healthcare Fund (Direct) | −1.26% | −1.40% | +12.80% | +13.46% | +23.47% | +16.24% | +14.40% |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | +11.62% | +13.76% |
Category average: the average of the 235 Thematic funds, same plan type.
Nippon India Taiwan Equity vs UTI - Healthcare: Year-wise Returns
| Year | Nippon India Taiwan EquityNippon India Taiwan Equity | UTI - HealthcareUTI - Healthcare |
|---|---|---|
| 2026to date | +66.72% | +16.63% |
| 2025 | +52.84% | −2.18% |
| 2024 | +25.96% | +44.27% |
| 2023 | +46.55% | +39.56% |
| 2022 | −33.29% | −11.30% |
| 2021 | -- | +20.35% |
Nippon India Taiwan Equity vs UTI - Healthcare: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of UTI - Healthcare Fund
Rolling returns
Every 3-year holding period, 434 of them, one for each trading day from 16-12-2024 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
Nippon India Taiwan Equity Fund (Direct)
UTI - Healthcare Fund (Direct)
BSE Healthcare TRI
to
Feb 2025Jun 2022
to
Jun 2025Sept 2022
to
Sept 2025Jan 2023
to
Jan 2026May 2023
to
May 2026Sept 2023
to
Sept 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity | 0.5 | 2.5 | 13.1 | 9.0 | 1.6 | 3.5 | 69.8 | 36.8% | 38.9% | −3.0% | 69.5% | 67% |
| UTI - Healthcare | 0.0 | 0.0 | 0.0 | 0.0 | 4.8 | 39.4 | 55.8 | 24.8% | 25.2% | 17.7% | 29.7% | 97% |
| BSE Healthcare TRI | 0.0 | 0.0 | 0.0 | 0.0 | 8.5 | 56.7 | 34.8 | 23.9% | 24.3% | 17.2% | 28.8% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is BSE Healthcare TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 14-12-2021. Past returns do not promise future returns.
Nippon India Taiwan Equity vs UTI - Healthcare: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 14-12-2021 to 30-10-2026: 59 instalments, ₹5,90,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| Nippon India Taiwan EquityNippon India Taiwan Equity Fund (Direct) | ₹5,90,000 | ₹17,24,248 | ₹11,34,248 | 45.5% |
| UTI - HealthcareUTI - Healthcare Fund (Direct) | ₹5,90,000 | ₹9,61,995 | ₹3,71,995 | 20.0% |
Nippon India Taiwan EquityNippon India Taiwan Equity Fund (Direct)
UTI - HealthcareUTI - Healthcare Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Nippon India Taiwan Equity vs UTI - Healthcare: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Nippon India Taiwan Equity Fund (Direct) | UTI - Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +75.71% | +13.46% |
| Standard deviation | 40.75% | 13.22% |
| Sharpe ratio | 1.73 | 0.62 |
| Sortino ratio | 2.48 | 0.91 |
| Maximum drawdown | −29.6% (30-07-2026) | −10.2% (23-10-2026) |
| Beta | -- | 0.93 |
| Alpha | -- | +1.60% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Nippon India Taiwan Equity Fund (Direct) | UTI - Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +54.78% | +23.47% |
| Standard deviation | 35.27% | 13.47% |
| Sharpe ratio | 1.38 | 1.30 |
| Sortino ratio | 2.03 | 1.84 |
| Maximum drawdown | −37.6% (09-04-2025) | −15.9% (03-03-2025) |
| Beta | -- | 0.92 |
| Alpha | -- | +1.87% |
From daily NAVs, 30-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Nippon India Taiwan Equity Fund (Direct) | UTI - Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +27.46% | +16.09% |
| Standard deviation | 32.62% | 15.17% |
| Sharpe ratio | 0.66 | 0.66 |
| Sortino ratio | 0.95 | 0.94 |
| Maximum drawdown | −44.8% (25-10-2022) | −27.1% (23-03-2020) |
| Beta | -- | 0.88 |
| Alpha | -- | +2.36% |
From daily NAVs, 14-12-2021 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Nippon India Taiwan Equity Fund (Direct)
UTI - Healthcare Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund (Direct) | −44.8% | 04-01-2022 | 25-10-2022 | 23-01-2024 | 15 months | −21.7% |
| UTI - Healthcare Fund (Direct) | −19.4% | 03-01-2022 | 17-06-2022 | 11-07-2023 | 13 months | −5.0% |
| BSE Healthcare TRI | −19.6% | 31-12-2021 | 17-06-2022 | 06-07-2023 | 13 months | −3.8% |
From daily values since 14-12-2021, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Nippon India Taiwan Equity Fund (Direct)
UTI - Healthcare Fund (Direct)
BSE Healthcare TRI
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 3-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Nippon India Taiwan Equity Fund (Direct)
UTI - Healthcare Fund (Direct)
BSE Healthcare TRI
Against BSE Healthcare TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| Nippon India Taiwan Equity Fund (Direct) | 81% | -29% | 36.74% |
| UTI - Healthcare Fund (Direct) | 96% | 89% | 3.31% |
From month-end values since 14-12-2021. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
Nippon India Taiwan Equity vs UTI - Healthcare: Portfolio Overlap
From each fund's latest monthly portfolio: Nippon India Taiwan Equity Fund, September 2026; UTI - Healthcare Fund, September 2026
Holdings in common
- Overlap
- 0.0%
- Held by both
- 0
- Only in Nippon India Taiwan Equity
- 0
- Only in UTI - Healthcare
- 44
Overlap: for each holding both funds own, the smaller of its two weights, added up. 0.0% means 0.0% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Nippon India Taiwan Equity Fund
Every holding of this fund is also held by the other.
Largest holdings only in UTI - Healthcare Fund
| Security | % of fund |
|---|---|
| EQ - SUN PHARMACEUTICALS INDUSTRIES | 7.62% |
| EQ - DIVIS LABORATORIES LTD. | 6.15% |
| EQ - DR REDDYS LABORATORIES LTD. | 5.24% |
| EQ - AJANTA PHARMA LTD. | 4.81% |
| EQ - GLAND PHARMA LTD. | 4.06% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Nippon India Taiwan Equity | UTI - Healthcare |
|---|---|---|
| Equity | 90.8% | 94.2% |
| Debt | 0.0% | 0.0% |
| Cash and others | 9.2% | 5.8% |
Market cap of stocks
| Market cap | Nippon India Taiwan Equity | UTI - Healthcare |
|---|---|---|
| Large Cap | 0.0% | 18.2% |
| Mid Cap | 0.0% | 33.6% |
| Small Cap | 0.0% | 39.2% |
| Foreign stocks | 90.8% | 0.0% |
| Not on AMFI's list | 0.0% | 3.1% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Nippon India Taiwan Equity | UTI - Healthcare |
|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0% | 68.5% |
| Semiconductors | 31.5% | 0.0% |
| Electronic Components | 25.1% | 0.0% |
| Healthcare Services | 0.0% | 23.3% |
| Semiconductor Materials & Equipment | 11.8% | 0.0% |
| Electronic Equipment & Instruments | 8.2% | 0.0% |
| Communications Equipment | 5.1% | 0.0% |
| Technology Hardware, Storage & Peripherals | 4.8% | 0.0% |
| Chemicals & Petrochemicals | 0.0% | 1.3% |
| Healthcare Equipment & Supplies | 0.0% | 1.1% |
The six largest sectors of each fund's stocks, % of the fund.
Nippon India Taiwan Equity vs UTI - Healthcare: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Nippon India Taiwan Equity Fund | UTI - Healthcare Fund |
|---|---|---|
| Total expense ratio (Direct) | 1.08% | 1.35% |
| Base expense ratio (Direct) | 0.80% | 1.06% |
| Total expense ratio (Regular) | 2.36% | 2.23% |
| Base expense ratio (Regular) | 1.92% | 1.84% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Nippon India Taiwan Equity with
Nippon India Taiwan Equity Fund vs UTI - Healthcare Fund: Frequently Asked Questions
What is the difference between Nippon India Taiwan Equity Fund and UTI - Healthcare Fund?
Nippon India Taiwan Equity Fund is a Thematic fund, UTI - Healthcare Fund is a Thematic fund, run by Nippon India Mutual Fund and UTI Mutual Fund. Their portfolios overlap 0.0%. Nippon India Taiwan Equity Fund charges 1.08% a year and UTI - Healthcare Fund 1.35%.
Which has given higher returns, Nippon India Taiwan Equity Fund or UTI - Healthcare Fund?
Over 1 year: Nippon India Taiwan Equity Fund +75.71%, UTI - Healthcare Fund +13.46%. Over 3 years: Nippon India Taiwan Equity Fund +54.78% a year, UTI - Healthcare Fund +23.47% a year. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, Nippon India Taiwan Equity Fund or UTI - Healthcare Fund?
Nippon India Taiwan Equity Fund charges less: 1.08% a year against 1.35%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Nippon India Taiwan Equity Fund and UTI - Healthcare Fund overlap?
0.0%. They hold 0 of the same securities. From each fund's latest monthly portfolio.
Which is riskier, Nippon India Taiwan Equity Fund or UTI - Healthcare Fund?
On SEBI's riskometer, Nippon India Taiwan Equity Fund is rated Very High and UTI - Healthcare Fund Very High. Over 3 years, the standard deviation of daily returns was 35.27% and 13.47% a year.
Which is better for SIP, Nippon India Taiwan Equity Fund or UTI - Healthcare Fund?
Over the last 3 years, a monthly SIP of ₹10,000 from 03-10-2023 to 30-10-2026 grew to ₹8,42,956 in Nippon India Taiwan Equity Fund (XIRR 59.7% a year) and ₹4,72,306 in UTI - Healthcare Fund (XIRR 16.1% a year). Both received 37 instalments. Past returns do not promise future returns.
Can I invest in both Nippon India Taiwan Equity Fund and UTI - Healthcare Fund?
Yes. 0.0% of each fund's money sits in the same holdings, so the two hold mostly different investments.
Who manages Nippon India Taiwan Equity Fund and UTI - Healthcare Fund?
Nippon India Taiwan Equity Fund: Kinjal Desai. UTI - Healthcare Fund: Kamal Gada FM 1, Not Applicable FM 2, Not Applicable FM 3.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.